RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 40, Issue 15, Pages 7347-7357
Publisher
Oxford University Press (OUP)
Online
2012-05-10
DOI
10.1093/nar/gks353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 Recombinase
- (2012) Fei Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening
- (2011) Fei Huang et al. ACS Chemical Biology
- Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis
- (2011) Chris P. Ryan et al. CHEMICAL COMMUNICATIONS
- Halenaquinone, a chemical compound that specifically inhibits the secondary DNA binding of RAD51
- (2011) Motoki Takaku et al. GENES TO CELLS
- Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
- (2010) Jen-Chung Ko et al. BIOCHEMICAL PHARMACOLOGY
- Targeting human Rad51 by specific DNA aptamers induces inhibition of homologous recombination
- (2010) Susan F. Martinez et al. BIOCHIMIE
- Design of Potent Inhibitors of Human RAD51 Recombinase Based on BRC Motifs of BRCA2 Protein: Modeling and Experimental Validation of a Chimera Peptide
- (2010) Julian Nomme et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides
- (2010) Mark E. B. Smith et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Mutation of the RAD51C gene in a Fanconi anemia–like disorder
- (2010) Fiona Vaz et al. NATURE GENETICS
- Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130
- (2010) D. C. Hegan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of RAD51 occurs in aggressive prostatic cancer
- (2009) Anita Mitra et al. HISTOPATHOLOGY
- Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
- (2009) L. A. Parsels et al. MOLECULAR CANCER THERAPEUTICS
- Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells
- (2009) Emilie Rass et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- DIDS, a chemical compound that inhibits RAD51-mediated homologous pairing and strand exchange
- (2009) Takako Ishida et al. NUCLEIC ACIDS RESEARCH
- The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
- (2009) James W Welsh et al. Radiation Oncology
- The consequences of Rad51 overexpression for normal and tumor cells
- (2008) Hannah L. Klein DNA REPAIR
- A forward chemical genetic screen reveals an inhibitor of the Mre11–Rad50–Nbs1 complex
- (2008) Aude Dupré et al. Nature Chemical Biology
- Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks
- (2008) W. Y. Mansour et al. NUCLEIC ACIDS RESEARCH
- A chemical compound that stimulates the human homologous recombination protein RAD51
- (2008) K. Jayathilaka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Use of the Rad51 promoter for targeted anti-cancer therapy
- (2008) C. M. Hine et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair
- (2008) Nicole Bennardo et al. PLoS Genetics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started